Literature DB >> 23208536

Lessons from the heart and ischemic limbs: midkine as anti-inflammatory mediator for kidney diseases?

Delia Lidia Şalaru1, Peter R Mertens.   

Abstract

Inflammatory responses ensuing ischemia involve the release of numerous mediators. Among these the heparin-binding growth factor midkine has been recognized as a potent inducer of neoangiogenesis. In a recent publication, the release of midkine has been studied in different in vitro models, and effects of abrogated midkine expression by means of genetic knockout has been analyzed in ischemia models of the limbs. The observed effects indicate a profound effect exerted by midkine under ischemia in the coordination of the inflammatory response and neoangiogenesis.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23208536     DOI： 10.1007/s11255-012-0344-4

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


  22 in total

1.  C-phycocyanin protects against ischemia-reperfusion injury of heart through involvement of p38 MAPK and ERK signaling.

Authors:  Mahmood Khan; Saradhadevi Varadharaj; Latha P Ganesan; Jagdish C Shobha; Madireddi U Naidu; Narasimham L Parinandi; Susheela Tridandapani; Vijay Kumar Kutala; Periannan Kuppusamy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-12-22       Impact factor: 4.733

2.  Endothelial HIF-2α regulates murine pathological angiogenesis and revascularization processes.

Authors:  Nicolas Skuli; Amar J Majmundar; Bryan L Krock; Rickson C Mesquita; Lijoy K Mathew; Zachary L Quinn; Anja Runge; Liping Liu; Meeri N Kim; Jiaming Liang; Steven Schenkel; Arjun G Yodh; Brian Keith; M Celeste Simon
Journal:  J Clin Invest       Date:  2012-03-19       Impact factor: 14.808

3.  Neointima formation in a restenosis model is suppressed in midkine-deficient mice.

Authors:  M Horiba; K Kadomatsu; E Nakamura; H Muramatsu; S Ikematsu; S Sakuma; K Hayashi; Y Yuzawa; S Matsuo; M Kuzuya; T Kaname; M Hirai; H Saito; T Muramatsu
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

4.  Midkine acts as proangiogenic cytokine in hypoxia-induced angiogenesis.

Authors:  Ludwig T Weckbach; Leopold Groesser; Julia Borgolte; Judith-Irina Pagel; Frank Pogoda; Jürgen Schymeinsky; Josef Müller-Höcker; Mehdi Shakibaei; Takashi Muramatsu; Elisabeth Deindl; Barbara Walzog
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-06-15       Impact factor: 4.733

5.  A conserved family of prolyl-4-hydroxylases that modify HIF.

Authors:  R K Bruick; S L McKnight
Journal:  Science       Date:  2001-10-11       Impact factor: 47.728

Review 6.  Targeted therapies of cancer: angiogenesis inhibition seems not enough.

Authors:  Ilse Roodink; William P J Leenders
Journal:  Cancer Lett       Date:  2010-12-18       Impact factor: 8.679

7.  Midkine gene transfer after myocardial infarction in rats prevents remodelling and ameliorates cardiac dysfunction.

Authors:  Arihiro Sumida; Mitsuru Horiba; Hisaaki Ishiguro; Hiroharu Takenaka; Norihiro Ueda; Hiroaki Ooboshi; Tobias Opthof; Kenji Kadomatsu; Itsuo Kodama
Journal:  Cardiovasc Res       Date:  2009-12-07       Impact factor: 10.787

8.  The growth factor Midkine antagonizes VEGF signaling in vitro and in vivo.

Authors:  Edward Htun van der Horst; Brendon T Frank; Lawrence Chinn; Angela Coxon; Shyun Li; Fanny Polesso; Anthony Slavin; Astrid Ruefli-Brasse; Holger Wesche
Journal:  Neoplasia       Date:  2008-04       Impact factor: 5.715

9.  High levels of urinary midkine in various cancer patients.

Authors:  Shinya Ikematsu; Kohji Okamoto; Yoshihiro Yoshida; Munehiro Oda; Hitomi Sugano-Nagano; Kinya Ashida; Hideshi Kumai; Kenji Kadomatsu; Hisako Muramatsu; Sadatoshi Sakuma
Journal:  Biochem Biophys Res Commun       Date:  2003-06-27       Impact factor: 3.575

Review 10.  Therapeutic angiogenesis for cardiovascular disease: biological context, challenges, prospects.

Authors:  Ian Zachary; Robert D Morgan
Journal:  Heart       Date:  2010-09-30       Impact factor: 5.994
View more
  3 in total

Review 1.  Loss of heparin-binding protein prevents necrotizing glomerulonephritis: first clues hint at plasminogen activator inhibitor-1.

Authors:  Delia Lidia Şalaru; Peter R Mertens; Peter Bartsch
Journal:  Int Urol Nephrol       Date:  2013-03-30       Impact factor: 2.370

2.  Midkine's Role in Cardiac Pathology.

Authors:  Kathleen C Woulfe; Carmen C Sucharov
Journal:  J Cardiovasc Dev Dis       Date:  2017-08-24

3.  Midkine release during hemodialysis is predictive of hypervolemia and associates with excess (cardiovascular) mortality in patients with end-stage renal disease: a prospective study.

Authors:  Sabine Brandt; Anja Fischer; Carla Kreutze; Dorothea Hempel; Xenia Gorny; Florian G Scurt; Delia L Şalaru; Peter Bartsch; Anja Bernhardt; Stefanie M Bode-Böger; Matthias Girndt; Roman Fiedler; Berend Isermann; Jonathan A Lindquist; Peter R Mertens
Journal:  Int Urol Nephrol       Date:  2022-02-24       Impact factor: 2.266
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.